MSB 2.98% $1.12 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-765

  1. 4,490 Posts.
    lightbulb Created with Sketch. 346
    Re mistakes, I'm confused, is it someone on the MSB payroll saying it's "effective or efficacious" or is it the FDA. Could have a tad difference on whether approval is imminent.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.